INTEGRATED BIOPHARMA, INC. (OTCMKTS:INBP) Files An 8-K Submission of Matters to a Vote of Security HoldersItem 5.07 Submission of Matters to a Vote of Security Holders
On November 27, 2017, the Company held its 2017 Annual Meeting of Shareholders (the "Annual Meeting"). A total of 21,135,174 shares of the Company's common stock, par value $0.002 per share, were entitled to vote as of the close of business on October 18, 2017, the record date for the Annual Meeting. The holders of 17,562,780 shares of common stock, a majority, were present in person or represented by proxy at the Annual Meeting, at which the shareholders were asked to vote on two proposals. The proposals are described in detail in the Company’s definitive proxy materials which were filed with the Securities and Exchange Commission and first made available to shareholders on or about October 27, 2017. Set forth below is the matters acted upon by the Company’s shareholders at the Annual Meeting, and the final voting results of each such proposal.
Proposal No. 1 –To elect three Class II directors for a three year term to serve until the 2020 Annual Meeting of Stockholders
The Company’s shareholders voted for the election of the three Class II directors to serve until the 2020 Annual Meeting of Stockholders. The final voting results were as follows:
|
Broker |
|||
|
For |
Withheld |
Non-Votes |
|
|
Christina Kay |
13,249,664 | 265,823 | 4,047,293 |
|
Robert Canarick |
13,249,614 | 265,873 | 4,047,293 |
|
William H Milmoe |
13,245,408 | 270,079 | 4,047,293 |
Proposal No. – To ratify the appointment of the Company’s independent auditors for the fiscal year ending June 30, 201
The Company’s shareholders voted in favor of ratifying the appointment of Friedman, LLP as the Company’s independent auditors for the fiscal year ending June 30, 2018. The final voting results were as follows:
|
For |
Against |
Abstain |
| 17,272,385 | 85,930 | 204,465 |
About INTEGRATED BIOPHARMA, INC. (OTCMKTS:INBP)
Integrated Biopharma Inc. is engaged in manufacturing, distributing, marketing and sales of vitamins, nutritional supplements and herbal products. The Company’s business segments include Contract Manufacturing operated by InB:Manhattan Drug Company, Inc.(MDC), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers and healthcare providers; Branded Proprietary Products operated by AgroLabs, Inc. (AgroLabs), which distributes nutritional products for sale through market, grocery, drug and vitamin retailers, under the brands of Naturally Noni, Coconut Water, Aloe Pure, Peaceful Sleep, Green Envy, ACAI Extra, ACAI Daily Cleanse and Wheatgrass, and offers other products, and Other Nutraceutical Businesses, which includes the operations of The Vitamin Factory, IHT Health Products, Inc. (IHT), MDC Warehousing and Distribution, Inc., and Chem International, Inc. Its customers are located in the United States, Luxembourg and Canada.
